Please login to the form below

Not currently logged in
Email:
Password:

Elsevier hires chief medical officer

Peter Edelstein is a veteran surgeon
Elsevier_Peter-Edelstein

Veteran surgeon and author Peter Edelstein has joined information solutions and publishing firm Elsevier as chief medial officer.

Edelstein will join Elsevier's clinical solutions management team, engaging with strategic partners, clients, and professional societies.

He brings more than 35 years of experience practicing medicine and in healthcare administration, joining from Reed Elsevier company LexisNexis Risk Solutions, where he was chief medical officer.

Edelstein was in private practice before joining the surgical faculty at Stanford University, where he focused on gastrointestinal, oncologic and trauma surgery. He is board certified by the American College of Surgeons and the American Society of Colon and Rectal Surgery.

"Dr Edelstein brings deep clinical and business experience to our team at Elsevier," said Jay Katzen, president of Elsevier Clinical Solutions.

"We will look for him to help us improve the way we engage with hospitals, health systems and other healthcare providers as they seek best-of-suite solutions to meet their workflow and evidence-based practice needs."

Edelstein said that he looking forward to working with Elsevier's 'talented and knowledgeable teams'.

“By applying my clinical and business experiences and perspectives, I hope to help Elsevier continue to grow and offer the best integrated solutions to our customers,” he added.

3rd July 2014

From: Marketing

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

Pandemic preparedness
The pandemic preparedness paradox
Why our efficient ‘just in time’ mentality must be replaced with a resilient ‘just in case’ activity...
Emre Vural
Sourcing R&D innovation: why pharma companies need to evolve their business models
Recent years have seen a significant shift in drug development to specialty areas...
2020 - a year to remember or forget?
2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...

Infographics